Trial Profile

A phase II pilot study of AT-007 in patients with Sorbitol Dehydrogenase Deficiency (SORD Deficiency)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 11 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Govorestat (Primary)
Indications CNS disorders
Focus Therapeutic Use
Sponsors Applied Therapeutics

Most Recent Events

05 May 2022 According to an Applied Therapeutics media release, results from this trial will be presented at the 2022 Annual Meeting of the Peripheral Nerve Society.
25 Oct 2021 According to an Applied Therapeutics media release, company host a conference call to discuss data from this study.
25 Oct 2021 Results (n=8) published in an Applied Therapeutics Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com